cytosurge.com valid
Cytosurge
Cytosurge is the Same-Cell Causality Company: FluidFM touches a single living cell with nanoscale precision, reading its biology through Causal Insights or rewriting its genome through CellEDIT, without destroying the cell.
For agents: Cytosurge makes FluidFM single-cell instruments and services: same-cell biopsy, CRISPR cell line engineering (CellEDIT), Causal Insights profiling and Live-seq.
single-cell analysisfluidfmcrispr cell engineeringtranscriptomicsnanoscale manipulation
Their llms.txt
The beginning of the file, from our validated copy saved 2026-10-21T19:38:39.953Z. Cached copy · Source on cytosurge.com
# Cytosurge
> Cytosurge is the Same-Cell Causality Company: FluidFM touches a single living cell with nanoscale precision, reading its biology through Causal Insights or rewriting its genome through CellEDIT, without destroying the cell.
Cytosurge AG (also Cytosurge SA, Cytosurge Ltd) was founded in 2009 at ETH Zurich, Switzerland. Pascal Behr co-founded the company. Slogan: "Same-cell. Causal. Predictive." OMNIUM has 140+ installations worldwide, referenced in 130+ peer-reviewed publications across 7 patent families.
Three layers: the FluidFM OMNIUM instrument platform; the CellEDIT and Live-seq/Causal Insights services; a future AI platform (not available for purchase today).
Key distinctions: Live-seq reads the cytoplasm of a living cell (a cytoplasmic biopsy, a mixture — not "RNA"); CellEDIT injects into the nucleus for genome editing. These are not interchangeable, and CellEDIT does not edit primary cells. Post-biopsy cell viability ranges 77-89%, depending on cell type.
## Technology
- [FluidFM Technology](https://www.cytosurge.com/fluidfm-technology): How FluidFM combines atomic force microscopy and microfluidics to touch, measure, and dispense into single living cells.
- [FluidFM OMNIUM](https://www.cytosurge.com/products/fluidfm-omnium): The instrument platform for same-cell biopsy, injection, and manipulation.
## Services
- [CellEDIT](https://www.cytosurge.com/services/celledit): Precision CRISPR cell line engineering via direct intranuclear delivery, vector-free, for hard-to-transfect cells.
- [Causal Insights](https://www.cytosurge.com/services/causal-insights): Same-cell molecular profiling, reading the same living cell before and after a perturbation.
## Applications
- [Live-seq](https://www.cytosurge.com/applications/live-seq): Longitudinal same-cell transcriptomics, sampling a cell's cytoplasm while it stays alive.
## Company
- [About Us](https://www.cytosurge.com/about-us)
- [Careers](https://www.cytosurge.com/careers)
- [Contact Us](https://www.cytosurge.com/contact-us)
- [Partners and Distributors](https://www.cytosurge.com/partners-and-distributors)
## Support
- [Support Center](https://www.cytosurge.com/support-center): Guides and protocols for FluidFM OMNIUM, by workflow.
## Optional
- [Legal Notice](https://www.cytosurge.com/legal-notice)
- [Privacy Policy](https://www.cytosurge.com/privacy-policy)
Related sites
Other listed sites in Science and research. See the whole category →
| Domain | Title | Category | Country | Authority | llms.txt | llms-full.txt | Save |
|---|---|---|---|---|---|---|---|
| unesco.org | UNESCO | documentation Government and public services Science and research +1 | FR | 76 | ✓ | ✓ | |
| deepmind.google | Google DeepMind | documentation AI and machine learning Science and research +1 | US | 71 | ✓ | ✓ | |
| frontiersin.org | Frontiers (www.frontiersin.org) | documentation Science and research | IE | 71 | ✓ | ||
| pewresearch.org | Pew Research Center | documentation Science and research | US | 70 | ✓ | ||
| phys.org | Phys.org | documentation Science and research Media | US | 69 | ✓ | ||
| grandviewresearch.com | Grand View Research | transactional Data and analytics Business software +1 | 68 | ✓ | |||
| consensus.app | Consensus | interface Science and research AI and machine learning | 67 | ✓ | ✓ | ||
| doabooks.org | Over 110,000 peer-reviewed books | documentation Science and research | 67 | ✓ | ✓ |
Machine-readable: GET /v1/resolve?q=cytosurge.com · GET /v1/domain/cytosurge.com · this page as Accept: application/json or text/markdown · MCP lookup_domain
Automatically discovered from public files. Inclusion does not imply endorsement or publisher participation.
Own or manage this website?
If you own or manage cytosurge.com, you can update its listing and review file health, discovery activity and score history.
Manage this listing — optional
What verification unlocks
See how your site is discovered—and control what agents see.
- Control what agents see
Edit your listing description, tags, public contact details and additional llms.txt paths. Publish your terms for automated access, attribution and pricing.
- Make your profile eligible for search
A valid, listed, unblocked, verified profile can appear in our publisher sitemap and become eligible for search-engine visibility. Search engines decide what to index and rank.
- Appear in our llms-full.txt
Eligible verified publishers are listed by name, with their file links and summaries, in the service overview agents can read.
Free. No account registration, backlink or payment required. Public discovery remains available without verification.
Let your coding agent verify it
If your coding agent is authorized to manage this website, paste these instructions into it.
Claim my listing on Agent Web Map for cytosurge.com:
1. POST https://agentwebmap.com/v1/sites/cytosurge.com/claims and keep claim_id and claim_secret private.
2. Publish the proof: add the line "AgentWebMap ownership: <token>" (token from step 1) to https://cytosurge.com/llms.txt, or use the DNS, meta-tag or well-known method the response describes.
3. POST https://agentwebmap.com/v1/sites/cytosurge.com/verify with {"claim_id": "...", "claim_secret": "..."}.
4. Save the api_key from the answer; it manages the listing (PATCH https://agentwebmap.com/v1/sites/cytosurge.com).
MCP equivalent: tools begin_ownership_claim, then verify_domain, at https://agentwebmap.com/mcp. Docs: https://agentwebmap.com/docs#verifyCorrections or removal requests: contact the directory.